Biogen (BIIB – Research Report) received a Hold rating and price target from Needham analyst Ami Fadia today. The company’s shares closed last Friday at $159.99. Don't Miss our Black Friday Offers: ...
Needham Aggressive Growth Fund earns an Above Average Process Pillar rating. The most important driver of the rating is the fund's impressive long-term risk-adjusted performance. This can be seen ...